Medication info
Teneglib M Sustained-release Tablet 20/1000 mg

Teneglib M Sustained-release Tablet 20/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›26mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Bionex Co., Ltd.
Appearance
Pink oval-shaped sustained-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201420 · Approved 2022.04.04 · Insurance code 643105620

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose is adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets at the same time once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's existing dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, the dose may be initiated at the patient's existing doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and the dose adjusted as appropriate. When administered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching from other glucose-lowering medicines. Because such a change may cause changes in blood glucose control, any change in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, this medicine should be swallowed whole and not split, crushed, ground, or chewed.

Ingredients

Manufacturer
Bionex Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication helps improve blood glucose control in patients with type 2 diabetes. It is used in a combination therapy with teneligliptin and metformin, assisting in effective management of blood glucose levels alongside dietary and exercise regimens. This contributes to enhanced blood glucose control and is expected to have positive effects on diabetes management.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose is adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets at the same time once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's existing dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, the dose may be initiated at the patient's existing doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and the dose adjusted as appropriate. When administered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching from other glucose-lowering medicines. Because such a change may cause changes in blood glucose control, any change in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, this medicine should be swallowed whole and not split, crushed, ground, or chewed.

Precautions

This medication can rarely cause a serious metabolic complication called lactic acidosis; therefore, it should not be administered to patients with impaired kidney function or liver dysfunction. The risk of hypoglycemia may increase when this medication is used with other diabetes treatments, so immediate action, such as consuming sugar, is necessary if hypoglycemia symptoms occur. This medication should not be administered to certain patient populations, such as those with moderate or severe impaired kidney function, heart failure, patients at risk for acute renal failure, type 1 diabetes patients, or pregnant women. At least 48 hours before a testing involving radiological iodine contrast materials, this medication should be stopped, and re-administered only after confirming normal kidney function afterwards. Caution should be exercised when administering this medication to patients with liver dysfunction, severe pulmonary dysfunction, serious infections, malnutrition, starvation, frailty, adrenal insufficiency, and administration can be temporarily halted if necessary. Since this medication contains tartrazine, which can cause allergic reactions, patients hypersensitive to this component should be careful. If there are persistent abdominal pain, vomiting, severe constipation, shortness of breath, fever, skin rash, or blisters during use, immediate consultation with a physician is required, as these symptoms may indicate serious side effects. Elderly patients should regularly undergo kidney function tests due to the potential for decreased renal function and should start with the minimum dosage to ensure adequate blood glucose control. It is recommended that pregnant and lactating women do not use this medication, and women who may become pregnant should confirm their pregnancy status before deciding to take the medication. In cases of overdose, immediate visit to a medical institution for appropriate treatment is necessary, as this medication can be removed by hemodialysis. Patients performing hazardous work or driving should use this medication with caution due to the risks of lactic acidosis or hypoglycemia. Additionally, this medication may interact with other drugs, so it is essential to inform the physician or pharmacist about any other medications being taken.

Side effects

  • Severe lactic acidosis
  • hypoglycemia
  • bowel obstruction
  • liver dysfunction
  • interstitial pneumonia
  • bullous pemphigoid
  • acute pancreatitis
  • dizziness
  • constipation
  • abdominal distension
Show 159 more
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyps
  • colonic polyps
  • duodenal ulcer
  • gastroesophageal reflux disease
  • diarrhea
  • appetite loss
  • amylase elevation
  • lipase elevation
  • AST (GOT) elevation
  • ALT (GPT) elevation
  • GGT elevation
  • ALP elevation
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • CK (CPK) elevation
  • serum potassium concentration elevation
  • malaise
  • allergic rhinitis
  • serum uric acid elevation
  • peripheral edema
  • herpes zoster
  • limb pain
  • epigastric pain
  • gastritis
  • upper respiratory infection
  • tremors
  • headache
  • asthenia
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • rhinitis
  • diaphoresis
  • diabetic retinopathy
  • visual impairment
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • diarrhea
  • chronic gastritis
  • irritable bowel syndrome
  • fatigue
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • neutropenia
  • abnormal blood glucose
  • increased blood glucose
  • increased blood pressure
  • hepatic coma
  • lumbar spinal canal stenosis
  • intervertebral disc protrusion
  • intervertebral disc disorder
  • spinal ligament ossification
  • spinal canal stenosis
  • rotator cuff syndrome
  • bladder mass
  • ureteral stones
  • urinary stones
  • coronary artery disease
  • unstable angina
  • gastroesophageal reflux disease
  • gastric polyps
  • gastritis
  • biliary obstruction
  • chronic cholecystitis
  • soft tissue infection
  • pneumonia
  • cataracts
  • depression
  • iliac artery stenosis
  • vertigo
  • benign prostatic hyperplasia
  • knee surgery
  • dizziness
  • diabetic neuropathy
  • paresthesia
  • muscle weakness
  • back pain
  • limb pain
  • tendinitis
  • cervical pain
  • bone pain
  • osteoarthritis
  • osteoporosis
  • muscle cramps
  • foot deformity
  • hypertrophic osteoarthritis
  • bursitis
  • spinal osteoarthritis
  • postmenopausal osteoporosis
  • vomiting
  • abdominal pain
  • gastrointestinal motility disorder
  • gastrointestinal motility reduction
  • enteritis
  • toothache
  • anal rectal discomfort
  • secondary mixed hyperlipidemia
  • hypertriglyceridemia
  • vitamin D deficiency
  • abnormal weight gain
  • essential hypertension
  • orthostatic hypotension
  • white coat hypertension
  • bleeding
  • abnormal sputum
  • dyspnea
  • acute respiratory distress
  • atelectasis
  • epistaxis
  • chest discomfort
  • fever
  • chills
  • generalized edema
  • injection site inflammation
  • chest pain
  • dysuria
  • renal cysts
  • nocturia
  • ovarian cysts
  • vulvar pruritus
  • menopausal symptoms
  • toxic hepatitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • eyelid injury
  • ligament sprain
  • lip injury
  • contusion
  • urticaria
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • coronary artery disease
  • angina
  • otalgia
  • iron deficiency anemia
  • food allergy
  • pressure ulcer.

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture exposure and kept at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the medication's effectiveness for a longer time.

Appearance and packaging

Appearance

Pink oval-shaped sustained-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.